ING Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

ING Group’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-23,250	Closed	-$2.26M	–	852
2018 Q4	$2.26M	Buy	23,250 +14,564	+168%	+$1.91M	0.05%	211
2018 Q3	$1.5M	Sell	8,686 -30,575	-78%	-$4.41M	0.03%	283
2018 Q2	$5.48M	Buy	39,261 +19,295	+97%	+$2.74M	0.1%	117
2018 Q1	$2.25M	Buy	19,966 +1,470	+8%	+$185K	0.04%	199
2017 Q4	$2.44M	Buy	18,496 +3,300	+22%	+$388K	0.04%	201
2017 Q3	$1.54M	Sell	15,196 -4,601	-23%	-$493K	0.03%	257
2017 Q2	$1.99M	Buy	19,797 +575	+3%	+$61.9K	0.04%	218
2017 Q1	$2.33M	Buy	19,222 +9,078	+89%	+$1.11M	0.04%	230
2016 Q4	$1.13M	Buy	+10,144	New	+$1.22M	0.02%	297

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ING Group's GWPH Position: Q1 2019 in Review

ING Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2019, closing a stake of 23,250 shares — an estimated $2.26M sold.

ING Group first reported a position in GWPH in Q4 2016 and held it in 9 quarters. The position peaked at $5.48M in Q2 2018. 320 funds tracked by Wall St. Rank hold GWPH as of Q1 2019.

ING Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
ING Group sold 23,250 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2019, an estimated $2.26M.
ING Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 9 quarters.
ING Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $5.48M in Q2 2018.
320 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2019.

Based on ING Group's 13F filing for Q1 2019, filed 13 May 2019.